Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615774-17-000682
Filing Date
2017-02-16
Accepted
2017-02-16 13:52:19
Documents
1
Period of Report
2017-02-08

Document Format Files

Seq Description Document Type Size
1 3 s105383_form3.html 3  
1 3 s105383_form3.xml 3 2782
  Complete submission text file 0001615774-17-000682.txt   4266
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address REGINA-KIRCHMAIER STRASSE 4 KAUFBEUREN 2M 87600
Business Address
Donhauser Peter D.O. (Reporting) CIK: 0001698234 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37606 | Film No.: 17617291